Janos L Tanyi
5PUBLICATIONS
68CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 25, 2023
Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian Cancer.Stephanie L Wethington, Payal D Shah, Lainie Martin
|Mar 06, 2023
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study.Talayeh S Ghezelayagh, Emily S Wu, Emma L Barber
|Nov 28, 2022
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study.Austin R Pantel, Sarah B Gitto, Mehran Makvandi
|Sep 07, 2022
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006).Janos L Tanyi, Leslie M Randall, Setsuko K Chambers
|Apr 13, 2018
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer.Janos L Tanyi, Sara Bobisse, Eran Ophir
Pageof 1
Frequent Collaborators
2 joint publications
Lainie P Martin
2 joint publications
Fiona Simpkins
2 joint publications
Nawar Latif
2 joint publications
Drew A Torigian
2 joint publications
Mark Morgan
1 joint publications
Annalisa Roberti
1 joint publications
Raphael Genolet
1 joint publications
Brian Czerniecki
1 joint publications
Aikaterini Semilietof
1 joint publications
Ioannis Xenarios
